AssetMark Inc’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.4K Buy
4,421
+1,401
+46% +$22.3K ﹤0.01% 1686
2025
Q4
$49K Buy
3,020
+2,708
+868% +$44.2K ﹤0.01% 1729
2025
Q3
$4.67K Buy
312
+111
+55% +$1.35K ﹤0.01% 2367
2025
Q2
$2.34K Buy
+201
New +$1.83K ﹤0.01% 2382
2024
Q2
Sell
-80
Closed -$257 2099
2024
Q1
$257 Sell
80
-4,861
-98% -$18.8K ﹤0.01% 1774
2023
Q4
$24.2K Buy
4,941
+1,498
+44% +$6.83K ﹤0.01% 1269
2023
Q3
$18.8K Sell
3,443
-622
-15% -$4.11K ﹤0.01% 1250
2023
Q2
$27.3K Buy
4,065
+1,462
+56% +$10.9K ﹤0.01% 1177
2023
Q1
$23K Buy
2,603
+575
+28% +$5.07K ﹤0.01% 1176
2022
Q4
$15.5K Buy
2,028
+625
+45% +$4.86K ﹤0.01% 1246
2022
Q3
$10K Buy
1,403
+331
+31% +$3.12K ﹤0.01% 1222
2022
Q2
$9K Buy
1,072
+827
+338% +$7.27K ﹤0.01% 1227
2022
Q1
$3K Buy
+245
New +$3.85K ﹤0.01% 1339
2021
Q2
Sell
-43
Closed -$2K 1310
2021
Q1
$2K Buy
+43
New +$2.33K ﹤0.01% 1152

Other funds holding ADPT